Kyverna Therapeutics, Inc. insider trading

KYTXNASDAQ

$6.22-0.30 (-4.60%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+2.3%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25

Unlock quarterly net flow

Key players

BCBeth C. SeidenbergDirector7.5659%of company
FEFred E. CohenDirector7.3503%of company
CSChristi ShawExecutive Chairperson0.1079%of company
WWWarner Weston BiddleChief Executive Officer0.0938%of company
RARyan Alexander JonesChief Financial Officer0.0905%of company
KMKaren Marie WalkerChief Technology Officer0.0366%of company
ITIan T. ClarkDirector0.0351%of company
MAMert AktarDirector0.0351%of company
NGNaji GehchanSee Remarks0.0291%of company
DKDaniel K. SpiegelmanDirector0.0269%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
KYTX	Beth C. SeidenbergDirector	Open market purchase$1M	+17.7%	$7.50	$1M	Dec 18, 2025	Dec 22, 2025
KYTX	Westlake BioPartners Opportunity Fund I, L.P.10% Owner	Open market purchase$1M	+18.1%	$7.50	$1M	Dec 18, 2025	Dec 22, 2025

End of history · 2 transactions